Chinese Journal of Dermatology ›› 2025, Vol. 58 ›› Issue (1): 9-19.doi: 10.35541/cjd.20240405
• Guidelines and Consensus • Previous Articles Next Articles
Chinese Association of Rehabilitation Dermatology; Chinese Association of Photodynamic Therapy and Rehabilitation; Photodynamic Therapy Cooperation Center, Chinese Society of Dermatology
Received:
2024-08-02
Revised:
2024-11-08
Online:
2025-01-15
Published:
2025-01-03
Contact:
Wang Xiuli; Chen Xiang; Gao Xinghua
E-mail:wangxiuli_1400023@tongji.edu.cn; chenxiangck@126.com; gaobarry@hotmail.com
Supported by:
Chinese Association of Rehabilitation Dermatology, Chinese Association of Photodynamic Therapy and Rehabilitation, Photodynamic Therapy Cooperation Center, Chinese Society of Dermatology . Expert consensus on clinical application of aminolevulinic acid photodynamic therapy in non-melanoma skin cancers (2025 edition)[J]. Chinese Journal of Dermatology, 2025, 58(1): 9-19.doi:10.35541/cjd.20240405
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
[1] | Fujimura T, Fujisawa Y, Otsuka A, et al. Editorial: recent developments in therapies and diagnostic tools for melanoma and non⁃melanoma skin cancer[J]. Front Med (Lausanne), 2020,7:613152. doi: 10.3389/fmed.2020.613152. |
[2] | Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability⁃adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019[J]. JAMA Oncol, 2022,8(3):420⁃444. doi: 10.1001/jamaoncol.2021.6987. |
[3] | Urban K, Mehrmal S, Uppal P, et al. The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990⁃2017[J]. JAAD Int, 2021,2:98⁃108. doi: 10.1016/j.jdin.2020.10.013. |
[4] | Albert A, Knoll MA, Conti JA, et al. Non⁃melanoma skin cancers in the older patient[J]. Curr Oncol Rep, 2019,21(9):79. doi: 10.1007/s11912⁃019⁃0828⁃9. |
[5] | Morton CA, Szeimies RM, Basset⁃Seguin N, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications ⁃ actinic keratoses, Bowen's disease and basal cell carcinomas[J]. J Eur Acad Dermatol Venereol, 2019,33(12):2225⁃2238. doi: 10.1111/jdv.16017. |
[6] | Morton CA, Szeimies RM, Basset⁃Séguin N, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications ⁃ field cancerization, photorejuvenation and inflammatory/infective dermatoses[J]. J Eur Acad Dermatol Venereol, 2020,34(1):17⁃29. doi: 10.1111/jdv.16044. |
[7] | Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience[J]. J Photochem Photobiol B, 1990,6(1⁃2):143⁃148. doi: 10.1016/1011⁃1344(90)85083⁃9. |
[8] | 王秀丽, 徐世正, 张春荣, 等. 5⁃氨基酮戊酸光动力学疗法治疗Bowen病[J]. 中国激光医学杂志, 1999,8(1):9⁃11. doi: 10. 3969/j.issn.1003⁃9430.1999.01.004. |
[9] | 徐世正, 王秀丽, 张春荣. δ-氨基酮戊酸光动力疗法治疗皮肤基底细胞癌和鳞状细胞癌[J]. 中华皮肤科杂志, 1999,32(3):185. doi: 10.3760/j.issn:0412⁃4030.1999.03.023. |
[10] | 中华医学会皮肤性病学分会光动力治疗研究中心, 中国康复医学会皮肤病康复专业委员会, 中国医学装备协会皮肤病与皮肤美容分会光医学治疗装备学组. 氨基酮戊酸光动力疗法皮肤科临床应用指南(2021版)[J]. 中华皮肤科杂志, 2021,54(1):1⁃9. doi: 10.35541/cjd.20200731. |
[11] | Schmults CD, Blitzblau R, Aasi SZ, et al. Basal cell skin cancer, version 2.2024, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023,21(11):1181⁃1203. doi: 10.6004/jnccn.2023.0056. |
[12] | Keyal U, Bhatta AK, Zhang G, et al. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2019,80(3):765⁃773. doi: 10.1016/j.jaad.2018.10.042. |
[13] | Mishchenko T, Balalaeva I, Gorokhova A, et al. Which cell death modality wins the contest for photodynamic therapy of cancer?[J]. Cell Death Dis, 2022,13(5):455. doi: 10.1038/s41419⁃022⁃04851⁃4. |
[14] | Gollnick SO, Brackett CM. Enhancement of anti⁃tumor immunity by photodynamic therapy[J]. Immunol Res, 2010,46(1⁃3):216⁃226. doi: 10.1007/s12026⁃009⁃8119⁃4. |
[15] | Ji J, Zhang Y, Chen WR, et al. DC vaccine generated by ALA⁃PDT⁃induced immunogenic apoptotic cells for skin squamous cell carcinoma[J]. Oncoimmunology, 2016,5(6):e1072674. doi: 10.1080/2162402X.2015.1072674. |
[16] | Zeng Q, Yang J, Ji J, et al. PD⁃L1 blockade potentiates the antitumor effects of ALA⁃PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma[J]. Oncoimmunology, 2022,11(1):2061396. doi: 10.1080/2162402X. 2022.2061396. |
[17] | Schmults CD, Blitzblau R, Aasi SZ, et al. NCCN Guidelines® insights: squamous cell skin cancer, version 1.2022[J]. J Natl Compr Canc Netw, 2021,19(12):1382⁃1394. doi: 10.6004/jnccn. 2021.0059. |
[18] | Kibbi N, Owen JL, Worley B, et al. Evidence⁃based clinical practice guidelines for extramammary paget disease[J]. JAMA Oncol, 2022,8(4):618⁃628. doi: 10.1001/jamaoncol.2021.7148. |
[19] | Yan J, Wang B, Zhang G, et al. Neoadjuvant photodynamic therapy: an updated therapeutic approach for non⁃melanoma skin cancers[J]. Curr Treat Options Oncol, 2024,25(6):813⁃826. doi: 10.1007/s11864⁃024⁃01209⁃0. |
[20] | Li C, Wang P, Wang D, et al. Fluorescence kinetics study of twice laser irradiation based HpD‐PDT for nonmelanoma skin cancer[J]. Lasers in Surgery and Medicine, 2022,54(7):945⁃954. doi: doi.org/10.1002/lsm.23538. |
[21] | Chen J, Zhang Y, Wang P, et al. Plum⁃blossom needling promoted PpIX fluorescence intensity from 5⁃aminolevulinic acid in porcine skin model and patients with actnic keratosis[J]. Photodiagnosis Photodyn Ther, 2016,15:182⁃190. doi: 10.1016/j.pdpdt.2016.06.012. |
[22] | Wu Y, Wang P, Zhang L, et al. Enhancement of photodynamic therapy for Bowen's disease using plum⁃blossom needling to augment drug delivery[J]. Dermatol Surg, 2018,44(12):1516⁃1524. doi: 10.1097/DSS.0000000000001608. |
[23] | Shi L, Zhou C, Li C, et al. Ulceration occurring after ALA⁃PDT combined with plum⁃blossom needle percussion for the treatment of pretibial Bowen's disease: a case report[J]. Photodiagnosis Photodyn Ther, 2020,32:101958. doi: 10.1016/j.pdpdt.2020.101958. |
[24] | Zhu L, Wang P, Zhang G, et al. Conventional versus daylight photodynamic therapy for actinic keratosis: a randomized and prospective study in China[J]. Photodiagnosis Photodyn Ther, 2018,24:366⁃371. doi: 10.1016/j.pdpdt.2018.10.010. |
[25] | Zheng Z, Zhang LL, Shi L, et al. What is the most relevent factor causing pain during ALA⁃PDT? A multi⁃center, open clinical pain score research trial of actinic keratosis, acne and condylomata acuminata[J]. Photodiagnosis Photodyn Ther, 2019,26:73⁃78. doi: 10.1016/j.pdpdt.2019.03.001. |
[26] | Wang B, Shi L, Zhang YF, et al. Gain with no pain? Pain management in dermatological photodynamic therapy[J]. Br J Dermatol, 2017,177(3):656⁃665. doi: 10.1111/bjd.15344. |
[27] | Zhang Y, Zhang H, Zhang L, et al. Modified 5⁃aminolevulinic acid photodynamic therapy to reduce pain in the treatment of moderate to severe acne vulgaris: a prospective, randomized, split⁃face study[J]. J Am Acad Dermatol, 2021,84(1):218⁃220. doi: 10.1016/j.jaad.2020.04.146. |
[28] | Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator⁃blinded, controlled, phaseⅢ study throughout Europe[J]. J Eur Acad Dermatol Venereol, 2015,29(12):2342⁃2348. doi: 10.1111/jdv.13228. |
[29] | Yu N, Luo X, Wei T, et al. Dermabrasion combined with photodynamic therapy: a new option for the treatment of non⁃melanoma skin cancer[J]. Lasers Med Sci, 2022,37(2):1255⁃1263. doi: 10.1007/s10103⁃021⁃03381⁃3. |
[30] | Yu N, Wu L, Su J, et al. Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult⁃to⁃treat basal cell carcinoma: a retrospective clinical study[J]. J Dermatolog Treat, 2023,34(1):2200871. doi: 10. 1080/09546634.2023.2200871. |
[31] | Jeremic G, Moore CC, Brandt MG, et al. Neoadjuvant use of photodynamic therapy in basal cell and squamous cell carcinomas of the face[J]. ISRN Dermatol, 2011,2011:809409. doi: 10.5402/2011/809409. |
[32] | Liao C, Wu M, Liu Y, et al. Advanced treatment of giant proliferating trichilemmal tumor: limited resection combined with neoadjuvant ALA⁃PDT[J]. Photodiagnosis Photodyn Ther, 2023:103870. doi: 10.1016/j.pdpdt.2023.103870. |
[33] | Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy ⁃ mechanisms, photosensitizers and combinations[J]. Biomed Pharmacother, 2018,106:1098⁃1107. doi: 10.1016/j.biopha.2018.07.049. |
[34] | Zhang GL, Keyal U, Shi L, et al. Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: single center experience[J]. Photodiagnosis Photodyn Ther, 2020,32:101980. doi: 10.1016/j.pdpdt.2020.101980. |
[35] | Savoia P, Cremona O, Fava P. New perspectives in the pharmacological treatment of non⁃melanoma skin cancer[J]. Curr Drug Targets, 2016,17(3):353⁃374. doi: 10.2174/138945 0116666150806123717. |
[36] | Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal⁃cell carcinoma[J]. N Engl J Med, 2012,366(23):2171⁃2179. doi: 10.1056/NEJMoa1113713. |
[37] | Criscione VD, Weinstock MA, Naylor MF, et al. Actinic keratoses: natural history and risk of malignant transformation in the veterans affairs topical tretinoin chemoprevention trial[J]. Cancer, 2009,115(11):2523⁃2530. doi: 10.1002/cncr.24284. |
[38] | Braathen LR, Szeimies RM, Basset⁃Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus[J]. J Am Acad Dermatol, 2007,56(1):125⁃143. doi: 10.1016/j.jaad.2006.06.006. |
[39] | Apalla Z, Sotiriou E, Chovarda E, et al. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo⁃controlled study[J]. Br J Dermatol, 2010,162(1):171⁃175. doi: 10.1111/j.1365⁃2133.2009. 09492.x. |
[40] | 中国康复医学会皮肤病康复专业委员会, 中华医学会皮肤性病学分会光动力治疗研究中心, 中国医学装备协会皮肤病与皮肤美容分会光医学治疗装备学组. 中国光线性角化病临床诊疗专家共识(2021)[J]. 中华皮肤科杂志, 2021,54(12):1048⁃1056. doi: 10.35541/cjd.20210561. |
[41] | Steeb T, Wessely A, Petzold A, et al. Evaluation of long⁃term clearance rates of interventions for actinic keratosis: a systematic review and network meta⁃analysis[J]. JAMA Dermatol, 2021,157(9):1066⁃1077. doi: 10.1001/jamadermatol.2021.2779. |
[42] | Zhang L, Zhao Z, Wang P, et al. Long⁃term improvement on photoaging after ALA photodynamic therapy for actinic keratosis: a retrospective study[J]. Photodiagnosis Photodyn Ther, 2021,33:102181. doi: 10.1016/j.pdpdt.2021.102181. |
[43] | Zhang G, Cao Z, Wang P, et al. Comparison of efficacy, adverse effects and costs between 20 % ALA⁃PDT and 10 % ALA⁃PDT for the treatment of actinic keratosis in Chinese patients[J]. Photodiagnosis Photodyn Ther, 2020,31:101605. doi: 10.1016/j.pdpdt.2019.101605. |
[44] | Fitzmaurice S, Eisen DB. Daylight photodynamic therapy: what is known and what is yet to be determined[J]. Dermatol Surg, 2016,42(3):286⁃295. doi: 10.1097/DSS.0000000000000633. |
[45] | Li J, Zhang Y, Zhang G, et al. Modified painless photodynamic therapy for facial multiple actinic keratosis in China: a prospective split⁃face control study[J]. Lasers Surg Med, 2023,55(10):871⁃879. doi: 10.1002/lsm.23728. |
[46] | Huang A, Nguyen JK, Austin E, et al. Updates on treatment approaches for cutaneous field cancerization[J]. Curr Dermatol Rep, 2019,8(3):122⁃132. doi: 10.1007/s13671⁃019⁃00265⁃2. |
[47] | Jansen M, Kessels J, Nelemans PJ, et al. Randomized trial of four treatment approaches for actinic keratosis[J]. N Engl J Med, 2019,380(10):935⁃946. doi: 10.1056/NEJMoa1811850. |
[48] | Lopes ML, Silva Júnior FL, Lima KC, et al. Clinicopathological profile and management of 161 cases of actinic cheilitis[J]. An Bras Dermatol, 2015,90(4):505⁃512. doi: 10.1590/abd1806⁃4841.20153848. |
[49] | Choi SH, Kim KH, Song KH. Efficacy of ablative fractional laser⁃assisted photodynamic therapy for the treatment of actinic cheilitis: 12⁃month follow⁃up results of a prospective, randomized, comparative trial[J]. Br J Dermatol, 2015,173(1):184⁃191. doi: 10.1111/bjd.13542. |
[50] | Yang Y, Shen S, Wang P, et al. Efficacy of photodynamic therapy in actinic cheilitis: a systematic review[J]. Photodiagnosis Photodyn Ther, 2022,38:102782. doi: 10.1016/j.pdpdt.2022.102782. |
[51] | Radakovic S, Dangl M, Tanew A. 5⁃Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12⁃month follow⁃up study on 21 patients[J]. J Eur Acad Dermatol Venereol, 2020,34(9):2011⁃2015. doi: 10.1111/jdv.16247. |
[52] | Tokez S, Wakkee M, Louwman M, et al. Assessment of cutaneous squamous cell carcinoma (cSCC) in situ incidence and the risk of developing invasive cSCC in patients with prior cSCC in situ vs the general population in the Netherlands, 1989⁃2017[J]. JAMA Dermatol, 2020,156(9):973⁃981. doi: 10.1001/jamadermatol.2020.1988. |
[53] | Lv T, Zhang JC, Miao F, et al. Aminoleveulinate photodynamic therapy (ALA⁃PDT) for Bowen's disease in a SLE patient: case report and literature review[J]. Photodiagnosis Photodyn Ther, 2017,18:20⁃23. doi: 10.1016/j.pdpdt.2017.01.002. |
[54] | Zhong S, Zhang R, Mei X, et al. Efficacy of photodynamic therapy for the treatment of Bowen's disease: an updated systematic review and meta⁃analysis of randomized controlled trials[J]. Photodiagnosis Photodyn Ther, 2020,32:102037. doi: 10.1016/j.pdpdt.2020.102037. |
[55] | Sharma A, Birnie AJ, Bordea C, et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022[J]. Br J Dermatol, 2023,188(2):186⁃194. doi: 10.1093/bjd/ljac042. |
[56] | Hu A, Moore C, Yu E, et al. Evaluation of patient⁃perceived satisfaction with photodynamic therapy for Bowen disease[J]. J Otolaryngol Head Neck Surg, 2010,39(6):688⁃696. |
[57] | Fang S, Zhang L, Wang P, et al. Real⁃world data of 5⁃aminolaevulinic acid⁃mediated photodynamic therapy for Bowen disease: a 10⁃year retrospective study in patients with darker⁃coloured skin (2011⁃2021)[J]. Clin Exp Dermatol, 2024,49(10):1190⁃1196. doi: 10.1093/ced/llae139. |
[58] | Salim A, Leman JA, McColl JH, et al. Randomized comparison of photodynamic therapy with topical 5⁃fluorouracil in Bowen's disease[J]. Br J Dermatol, 2003,148(3):539⁃543. doi: 10.1046/j.1365⁃2133.2003.05033.x. |
[59] | 徐世正, 王秀丽, 徐威, 等. δ⁃氨基酮戊酸光动力治疗皮肤癌的评估[J]. 中华医学杂志(英文版), 2002,115(8):1141⁃1145. doi: 10.3760/j.issn:0366⁃6999.2002.08.005. |
[60] | Kaprin AD, Ivanova⁃Radkevich VI, Urlova AN, et al. Photodynamic therapy opportunities for the treatment of erythroplasia of Queyrat[J]. Biomedical Photonics, 2020,9(1):34⁃41. doi: 10.24931/2413⁃9432⁃2020⁃9⁃1⁃34⁃41. |
[61] | Work Group, Invited Reviewers, Kim J, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2018,78(3):560⁃578. doi: 10.1016/j.jaad. 2017.10.007. |
[62] | 中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌诊疗专家共识(2021)[J]. 中华皮肤科杂志, 2021,54(8):653⁃664. doi: 10.35541/cjd.20201140. |
[63] | Shi L, Wang H, Chen K, et al. Chinese guidelines on the clinical application of 5⁃aminolevulinic acid⁃based photodynamic therapy in dermatology (2021 edition)[J]. Photodiagnosis Photodyn Ther, 2021,35:102340. doi: 10.1016/j.pdpdt.2021. 102340. |
[64] | Peng J, Feng W, Luo X, et al. A clinical trial using attrition combined with 5⁃aminolevulinic acids based photodynamic therapy in treating squamous cell carcinoma[J]. Med Sci Monit, 2017,23:1347⁃1354. doi: 10.12659/msm.900420. |
[65] | Fang S, Zhou Z, Wu Y, et al. Photodynamic therapy combined with carbon dioxide laser for successful treatment of cutaneous squamous cell carcinoma within a long⁃standing and huge seborrheic keratosis[J]. Photodiagnosis Photodyn Ther, 2021,36:102536. doi: 10.1016/j.pdpdt.2021.102536. |
[66] | Bu W, Wang Y, Chen X, et al. Novel strategy in giant cutaneous squamous cell carcinoma treatment: the case experience with a combination of photodynamic therapy and surgery[J]. Photodiagnosis Photodyn Ther, 2017,19:116⁃118. doi: 10.1016/j.pdpdt.2017.05.006. |
[67] | 陈璋, 何平, 龙剑. 外科手术联合5⁃氨基酮戊酸光动力疗法治疗皮肤肿瘤的效果及预后分析[J]. 深圳中西医结合杂志, 2021,31(14):126⁃127. doi: 10.16458/j.cnki.1007⁃0893.2021.14. 055. |
[68] | Huang J, Liu Y, Wu M, et al. Successful treatment of a giant keratoacanthoma⁃like squamous cell carcinoma in the eyebrow using surgery combined with photodynamic therapy: a case report[J]. Photodiagnosis Photodyn Ther, 2021,35:102474. doi: 10. 1016/j.pdpdt.2021.102474. |
[69] | Chen Q, Jiang L, Shi L, et al. Successful treatment of upper⁃left eyelid squamous cell carcinoma in an epidermodysplasia verruciformis patient by ALA⁃PDT/holmium laser combination therapy[J]. Photodiagnosis Photodyn Ther, 2021,34:102277. doi: 10.1016/j.pdpdt.2021.102277. |
[70] | Ji J, Zhang Y, Chen WR, et al. DC vaccine generated by ALA⁃PDT⁃induced immunogenic apoptotic cells for skin squamous cell carcinoma[J]. Oncoimmunology, 2016,5(6):e1072674. doi: 10.1080/2162402X.2015.1072674. |
[71] | Keyal U, Bhatta AK, Zhang G, et al. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2019,80(3):765⁃773. doi: 10.1016/j.jaad.2018.10.042. |
[72] | Wang P, Zhang G, Zhang L, et al. 5⁃Aminolevulinic acid photodynamic therapy for early⁃stage lip squamous cell carcinoma[J]. Photodiagnosis Photodyn Ther, 2021,35:102321. doi: 10.1016/j.pdpdt.2021.102321. |
[73] | Yan J, Wang P, Li L, et al. Surgery sequential with 5⁃aminolevulinic acid photodynamic therapy for lip squamous cell carcinoma: two cases reports[J]. Photodiagnosis Photodyn Ther, 2020,32:102043. doi: 10.1016/j.pdpdt.2020.102043. |
[74] | Fargnoli MC, Kostaki D, Piccioni A, et al. Photodynamic therapy for the treatment of microinvasive squamous cell carcinoma of the lower lip: a case report[J]. G Ital Dermatol Venereol, 2015,150(3):331⁃335. |
[75] | Wang Y, Yang Y, Yang Y, et al. Surgery combined with topical photodynamic therapy for the treatment of squamous cell carcinoma of the lip[J]. Photodiagnosis Photodyn Ther, 2016,14:170⁃172. doi: 10.1016/j.pdpdt.2016.04.008. |
[76] | He X, Zhang J, Tan L, et al. Treatment of verrucous carcinoma in penis with topical aminolevulinic acid photodynamic therapy: an effective and safe treatment method[J]. Photodiagnosis Photodyn Ther, 2018,24:232⁃236. doi: 10.1016/j.pdpdt.2018.08. 015. |
[77] | 赵莉佩, 齐蔓莉. 260例皮肤恶性肿瘤及癌前病变回顾性分析[J]. 皮肤病与性病, 2023,45(3):209⁃211,220. doi: 10.3969/j.issn.1002⁃1310.2023.03.015. |
[78] | Liao C, Wu M, Liu Y, et al. Advanced treatment of giant proliferating trichilemmal tumor: limited resection combined with neoadjuvant ALA⁃PDT[J]. Photodiagnosis Photodyn Ther, 2023:103870. doi: 10.1016/j.pdpdt.2023.103870. |
[79] | 中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤基底细胞癌诊疗专家共识(2021)[J]. 中华皮肤科杂志, 2021,54(9):757⁃764. doi:10.35541/cjd.20201139. |
[80] | Christensen E, Mørk C, Skogvoll E. High and sustained efficacy after two sessions of topical 5⁃aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10⁃year follow⁃up study[J]. Br J Dermatol, 2012,166(6):1342⁃1348. doi: 10.1111/j.1365⁃2133.2012.10878.x. |
[81] | Liao C, Shi L, Wang D, et al. Bimodal photodynamic therapy for treatment of a 91⁃year⁃old patient with locally advanced cutaneous basal cell carcinoma and postoperative scar management[J]. Photodiagnosis Photodyn Ther, 2021,36:102553. doi: 10.1016/j.pdpdt.2021.102553. |
[82] | van Delft L, Nelemans PJ, Kessels J, et al. Long⁃term efficacy of photodynamic therapy with fractionated 5⁃aminolevulinic acid 20% versus conventional two⁃stage topical methyl aminolevulinate for superficial basal⁃cell carcinoma[J]. Dermatology, 2022,238(6):1044⁃1049. doi: 10.1159/000524745. |
[83] | Cosgarea R, Susan M, Crisan M, et al. Photodynamic therapy using topical 5⁃aminolaevulinic acid vs. surgery for basal cell carcinoma[J]. J Eur Acad Dermatol Venereol, 2013,27(8):980⁃984. doi: 10.1111/j.1468⁃3083.2012.04619.x. |
[84] | Liao C, Zhang G, Wang P, et al. Combination curettage and modified ALA⁃PDT for multiple basal cell carcinomas of the face and head[J]. Photodiagnosis Photodyn Ther, 2021,35:102393. doi: 10.1016/j.pdpdt.2021.102393. |
[85] | Kang Z, Zhang Q, Zhang Q, et al. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients[J]. Int J Clin Exp Pathol, 2015,8(10):13233⁃13240. |
[86] | St Claire K, Hoover A, Ashack K, et al. Extramammary Paget disease[J]. Dermatol Online J, 2019,25(4):13030/qt7qg8g292 [pii]. |
[87] | 《乳房外Paget病诊治专家共识(2024版)》编写委员会专家组. 乳房外Paget病诊治专家共识(2024版)[J]. 中华皮肤科杂志, 2024,57(5):400⁃408. doi: 10.35541/cjd.20230603. |
[88] | Snast I, Sharon E, Kaftory R, et al. Nonsurgical treatments for extramammary Paget disease: a systematic review and meta⁃analysis[J]. Dermatology, 2020,236(6):493⁃499. doi: 10.1159/000506832. |
[89] | Nardelli AA, Stafinski T, Menon D. Effectiveness of photodynamic therapy for mammary and extra⁃mammary Paget's disease: a state of the science review[J]. BMC Dermatol, 2011,11:13. doi: 10.1186/1471⁃5945⁃11⁃13. |
[90] | Wang HW, Lv T, Zhang LL, et al. A prospective pilot study to evaluate combined topical photodynamic therapy and surgery for extramammary paget's disease[J]. Lasers Surg Med, 2013,45(5):296⁃301. doi: 10.1002/lsm.22142. |
[91] | 严建娜, 吴赟, 陈裕充, 等. 手术联合氨基酮戊酸光动力治疗乳房外Paget病对复发的影响[J]. 中华皮肤科杂志, 2018,51(2):112⁃115. doi: 10.3760/cma.j.issn.0412⁃4030.2018.02.006. |
[92] | Li C, Guo L, Wang P, et al. ALA⁃PDT combined with holmium laser therapy of postoperative recurrent extramammary Paget's disease[J]. Photodiagnosis Photodyn Ther, 2019,27:92⁃94. doi: 10.1016/j.pdpdt.2019.05.011. |
[93] | Shen S, Zhang G, Wang P, et al. ALA⁃PDT as palliative care in a patient with secondary perineum EMPD[J]. Photodiagnosis Photodyn Ther, 2018,22:166⁃168. doi: 10.1016/j.pdpdt.2018.04. 002. |
[94] | Fontanelli R, Papadia A, Martinelli F, et al. Photodynamic therapy with M⁃ALA as non surgical treatment option in patients with primary extramammary Paget's disease[J]. Gynecol Oncol, 2013,130(1):90⁃94. doi: 10.1016/j.ygyno.2013.04.008. |
[95] | Wang D, Wang P, Li C, et al. Efficacy and safety of HpD⁃PDT for extramammary Paget's disease refractory to conventional therapy: a prospective, open⁃label and single arm pilot study[J]. Photodiagnosis Photodyn Ther, 2022,37:102670. doi: 10.1016/j.pdpdt.2021.102670. |
[1] | Combination of Traditional and Western Medicine Dermatology, Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on reflectance confocal microscopic features of common non-melanocytic skin tumors (2025 edition) [J]. Chinese Journal of Dermatology, 2025, 58(1): 20-33. |
[2] | Chinese Association of Rehabilitation Dermatology, Working Group on Geriatric Dermatology, Combination of Traditional and Western Medicine Dermatology. Expert consensus on the diagnosis, treatment, and rehabilitation of pruritus in the elderly (2025 edition) [J]. Chinese Journal of Dermatology, 2025, 58(1): 1-8. |
[3] | Liao Caihe, Wang Peiru, Wu Mingshun, Sun Xiaofei, Zhang Guolong, Wang Xiuli. Efficacy and safety of combination therapy with aminolevulinic acid photodynamic therapy in the treatment of facial basal cell carcinoma in the elderly: a retrospective analysis [J]. Chinese Journal of Dermatology, 2025, 58(1): 34-39. |
[4] | Xiang Xi, Zhang Lingyan, Zhong Lin, Gao Yi, Qiu Li. Multimodal ultrasound manifestations of port-wine stains and their application in efficacy assessment of photodynamic therapy [J]. Chinese Journal of Dermatology, 2024, 57(9): 801-806. |
[5] | Combination of Traditional and Western Medicine Dermatology, Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on the application of reflectance confocal microscopy in common melanocytic skin tumors(2024) [J]. Chinese Journal of Dermatology, 2024, 57(9): 775-784. |
[6] | Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594. |
[7] | The Consensus Development Expert Group of Hematoporphyrin Monomethyl Ether-mediated Photodynamic Therapy for Treating Port-wine Stains. Expert consensus on hematoporphyrin monomethyl ether-mediated photodynamic therapy for treating port-wine stains (2024) [J]. Chinese Journal of Dermatology, 2024, 57(7): 581-589. |
[8] | Chinese Society of Dermatology, Dermatology and Venereology Branch of Chinese Association of Rehabilitation Medicine, China Dermatologist Association. Expert consensus on the clinical application of allergen-specific IgE tests in atopic dermatitis (2024 edition) [J]. Chinese Journal of Dermatology, 2024, 57(6): 493-502. |
[9] | Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement ()”. Treatment of extramammary Paget′s disease: a Chinese expert consensus statement (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 400-408. |
[10] | Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434. |
[11] | China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417. |
[12] | Chinese Society of Dermatology, China Dermatologist Association, Chinese Association of Integrative Medicine Board of Dermatovenereology. Expert consensus on the clinical application of chemical peeling in China (2024 public version) [J]. Chinese Journal of Dermatology, 2024, 0(5): 20230620-e20230620. |
[13] | Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection (2024) [J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208. |
[14] | China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Expert consensus on the application and management of therapeutic drugs for atopic dermatitis (2024) [J]. Chinese Journal of Dermatology, 2024, 57(2): 97-108. |
[15] | Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(2): 109-118. |
|